Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Feuerstein: Amarin's Sloooow Vascepa Launch
TheStreet.com
Tuesday, March 26, 2013 - 10:20am
tags:
Amarin, Vascepa, drug launches
Phytopharm gives up after Parkinson's drug failure
Reuters
Tuesday, March 26, 2013 - 10:19am
tags:
Parkinson's Disease, Phytopharm, Cogane
Shire to Buy Eye-Drug Maker SARcode for $160 Million
Bloomberg
Tuesday, March 26, 2013 - 10:18am
tags:
SARcode, M&A, Shire
Pfizer's drug to treat tuberculosis in short supply
Reuters
Tuesday, March 26, 2013 - 10:17am
tags:
Pfizer, tuberculosis, drug shortages, Rifampin
Why Amarin Is Struggling So Much
Seeking Alpha
Tuesday, March 26, 2013 - 10:16am
tags:
Amarin, GSK
Otsuka to Pay Lundbeck $825 Million for Alzheimer’s Drug
Bloomberg
Tuesday, March 26, 2013 - 10:15am
tags:
Otsuka, Alzheimer's disease, Lu AE58054
Aubagio EU Backing Comes With Generic Worries
Seeking Alpha
Tuesday, March 26, 2013 - 9:33am
tags:
Aubagio, Europe, generics, Sanofi, MS, multiple sclerosis
Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Motley Fool
Tuesday, March 26, 2013 - 9:20am
tags:
diabetes, FDA, Eli Lilly, Boehringer Ingelheim, empagliflozin
J&J recalling more than 2 mln blood glucose meters worldwide
Reuters
Monday, March 25, 2013 - 12:17pm
tags:
JNJ, LifeScan, recalls, blood glucose monitoring
Obagi Medical Sued by Investor Over $360 Million Offer
Bloomberg
Monday, March 25, 2013 - 12:16pm
tags:
Obagi Medical Products, M&A, Valeant Pharmaceuticals
BioMarin: Gains To Continue As Pipeline Progress Is Realized
Seeking Alpha
Monday, March 25, 2013 - 12:15pm
tags:
Biomarin
Cytokinetics: Critical Phase IIb Data Is Upcoming In 2013 For Omecamtiv Mecarbil And Tirasemtiv
Seeking Alpha
Monday, March 25, 2013 - 12:06pm
tags:
Cytokinetics, Omecamtiv Mecarbil, Tirasemtiv
Idenix Loses First Phase Of Patent Dispute With Gilead Sciences
TheStreet.com
Monday, March 25, 2013 - 12:05pm
tags:
Gilead, Idenix, patents, hepatitis C, sofosbuvir
Vanda reports successful completion of pre-NDA meeting with FDA on tasimelteon
Yahoo/Fly on the Wall
Monday, March 25, 2013 - 11:11am
tags:
FDA, tasimelteon, Vanda, non-24 hour disorder
Sarepta set to rise if seeks quick drug OK
Reuters
Monday, March 25, 2013 - 11:09am
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Theravance Seen Luring Glaxo Bid as Drugs Near FDA Nod: Real M&A
Bloomberg
Monday, March 25, 2013 - 11:07am
tags:
GSK, Theravance, M&A
FDA Denies Approval For Glaxo Bird Flu Vaccine
Pharmalot
Monday, March 25, 2013 - 11:06am
tags:
FDA, GSK, bird flu, vaccines, Q-Pan H5N1
Sanofi to Seek More Venture-Capital Deals
Bloomberg
Monday, March 25, 2013 - 11:05am
tags:
Sanofi, venture capital, Warp Drive Bio
FDA rejects United Therapeutics' oral hypertension drug again
Reuters
Monday, March 25, 2013 - 11:03am
tags:
antihypertensives, FDA, United Therapeutics, Treprostinil
Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind
Seeking Alpha
Monday, March 25, 2013 - 11:00am
tags:
patent cliff, M&A, Teva, Pfizer, Novartis, GSK, Dendreon, AstraZeneca, Advaxis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.